GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Cyclically Adjusted PB Ratio

International Biotechnology Trust (LSE:IBT) Cyclically Adjusted PB Ratio : 0.85 (As of Jun. 19, 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Cyclically Adjusted PB Ratio?

As of today (2024-06-19), International Biotechnology Trust's current share price is £6.48. International Biotechnology Trust's Cyclically Adjusted Book per Share for the fiscal year that ended in Aug23 was £7.64. International Biotechnology Trust's Cyclically Adjusted PB Ratio for today is 0.85.

The historical rank and industry rank for International Biotechnology Trust's Cyclically Adjusted PB Ratio or its related term are showing as below:

LSE:IBT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.72   Med: 1.52   Max: 2.85
Current: 0.85

During the past 13 years, International Biotechnology Trust's highest Cyclically Adjusted PB Ratio was 2.85. The lowest was 0.72. And the median was 1.52.

LSE:IBT's Cyclically Adjusted PB Ratio is ranked better than
65.96% of 658 companies
in the Biotechnology industry
Industry Median: 1.665 vs LSE:IBT: 0.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

International Biotechnology Trust's adjusted book value per share data of for the fiscal year that ended in Aug23 was £6.875. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £7.64 for the trailing ten years ended in Aug23.

Shiller PE for Stocks: The True Measure of Stock Valuation


International Biotechnology Trust Cyclically Adjusted PB Ratio Historical Data

The historical data trend for International Biotechnology Trust's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Cyclically Adjusted PB Ratio Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 1.39 1.21 0.94 0.84

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.94 - 0.84 -

Competitive Comparison of International Biotechnology Trust's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, International Biotechnology Trust's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Cyclically Adjusted PB Ratio falls into.



International Biotechnology Trust Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

International Biotechnology Trust's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.48/7.64
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust's Cyclically Adjusted Book per Share for the fiscal year that ended in Aug23 is calculated as:

For example, International Biotechnology Trust's adjusted Book Value per Share data for the fiscal year that ended in Aug23 was:

Adj_Book=Book Value per Share/CPI of Aug23 (Change)*Current CPI (Aug23)
=6.875/129.4000*129.4000
=6.875

Current CPI (Aug23) = 129.4000.

International Biotechnology Trust Annual Data

Book Value per Share CPI Adj_Book
201408 3.957 99.900 5.125
201508 5.851 100.300 7.549
201608 5.751 101.200 7.354
201708 6.729 104.000 8.372
201808 6.990 106.500 8.493
201908 6.239 108.300 7.455
202008 7.386 108.800 8.784
202108 7.824 112.100 9.031
202208 6.972 121.800 7.407
202308 6.875 129.400 6.875

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


International Biotechnology Trust  (LSE:IBT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


International Biotechnology Trust Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines